HuGE Literature Finder
Records 1-15
|
Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer.
Cancer research and treatment : official journal of Korean Cancer Association 2020 Dec . Dong Si-Qi, Wang Tong-Min, Zhang Jiang-Bo, He Yong-Qiao, Xue Wen-Qiong, Wu Zi-Yi, Yang Da-Wei, Cao Lian-Jing, Huang Jing-Wen, Li Xi-Zhao, Zhang Pei-Fen, Zheng Xiao-Hui, Jia Wei-H |
|
Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: an IPD meta-analysis.
Pharmacological research 2019 Dec 104594. Hamzic Seid, Kummer Dominic, Froehlich Tanja K, Joerger Markus, Aebi Stefan, Palles Claire, Thomlinson Ian, Meulendijks Didier, Schellens Jan H M, García-González Xandra, López-Fernández Luis A, Amstutz Ursula, Largiadèr Carlo |
|
Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer.
Cancer communications (London, England) 2019 Oct 39 (1): 57. Lin Shaoyan, Yue Jian, Guan Xiuwen, Yuan Peng, Wang Jiayu, Luo Yang, Fan Ying, Cai Ruigang, Li Qiao, Chen Shanshan, Zhang Pin, Li Qing, Ma Fei, Xu Bing |
|
Genotype-based selection of treatment for patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology 2017 Nov . Abad A, Martínez-Balibrea E, Viéitez J M, Orduña V A, García Alfonso P, Manzano J L, Massutí B, Benavides M, Carrato A, Zanui M, Gallego J, Grávalos C, Conde V, Provencio M, Valladares M, Salazar R, Sastre J, Montagut C, Rivera F, Aranda |
|
Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant Capecitabine.
European journal of clinical pharmacology 2016 Nov . Roberto Michela, Romiti Adriana, Botticelli Andrea, Mazzuca Federica, Lionetto Luana, Gentile Giovanna, Paris Ida, Falcone Rosa, Bassanelli Maria, Di Pietro Francesca Romana, Onesti Concetta Elisa, Anselmi Elisabetta, Macrini Serena, Simmaco Maurizio, Marchetti Pao |
|
Pancytopenia and Severe Gastrointestinal Toxicities Associated with 5-Fluorouracil in a Patient with Thymidylate Synthase (TYMS) Polymorphism.
Cureus 2016 Sep 8 (9): e798. Wang Bo, Walsh Shannon J, Saif Muhammad |
|
Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G>C Substitution in the First 28-bp tandem repeat of the thymidylate synthase 2R Allele.
International journal of cancer. Journal international du cancer 2015 Jul . Meulendijks Didier, Jacobs Bart A W, Aliev Abidin, Pluim Dick, van Werkhoven Erik, Deenen Maarten J, Beijnen Jos H, Cats Annemieke, Schellens Jan H |
|
Polymorphisms in folate pathway genes are not associated with somatic nondisjunction in turner syndrome.
American journal of medical genetics. Part A 2015 Jul 167 (7): 1510-7. Bispo Adriana Valéria Sales, dos Santos Luana Oliveira, de Barros Juliana Vieira, Duarte Andrea Rezende, Araújo Jacqueline, Muniz Maria Tereza Cartaxo, Santos Nei |
|
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy.
Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
|
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS.
Gut 2015 Jan 64 (1): 111-20. Rosmarin Dan, Palles Claire, Pagnamenta Alistair, Kaur Kulvinder, Pita Guillermo, Martin Miguel, Domingo Enric, Jones Angela, Howarth Kimberley, Freeman-Mills Luke, Johnstone Elaine, Wang Haitao, Love Sharon, Scudder Claire, Julier Patrick, Fernández-Rozadilla Ceres, Ruiz-Ponte Clara, Carracedo Angel, Castellvi-Bel Sergi, Castells Antoni, Gonzalez-Neira Anna, Taylor Jenny, Kerr Rachel, Kerr David, Tomlinson I |
|
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity.
British journal of cancer 2013 Jun 108 (12): 2505-15. Loganayagam A, Arenas Hernandez M, Corrigan A, Fairbanks L, Lewis C M, Harper P, Maisey N, Ross P, Sanderson J D, Marinaki A |
|
Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer.
The pharmacogenomics journal 2011 Feb 11 (1): 61-71. Glimelius B, Garmo H, Berglund A, Fredriksson L A, Berglund M, Kohnke H, Byström P, Sørbye H, Wadelius |
|
Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies.
Leukemia research 2009 Jan 33 (1): 82-7. Kim Hee Nam, Kim Yeo-Kyeoung, Lee Il-Kwon, Yang Deok-Hwan, Lee Je-Jung, Shin Min-Ho, Park Kyeong-Soo, Choi Jin-Su, Park Moo Rim, Jo Deog Yeon, Won Jong Ho, Kwak Jae-Yong, Kim Hyeoung-Jo |
|
Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring.
Neuroscience letters 2009 Jan 449 (1): 15-9. Coppedè Fabio, Migheli Francesca, Bargagna Stefania, Siciliano Gabriele, Antonucci Ivana, Stuppia Liborio, Palka Giandomenico, Migliore Luc |
|
Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.
British journal of haematology 2007 Feb 136 (4): 590-6. Bolufer Pascual, Collado Maria, Barragan Eva, Calasanz María-José, Colomer Dolors, Tormo Mar, González Marcos, Brunet Salut, Batlle Montserrat, Cervera José, Sanz Miguel-Ang |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jun 16, 2021
- Content source: